Market News: The Ukrainian military said that the attack on the Russian oil depot triggered a "fire".Xpeng Motors: Tucki P7+ completed the formal delivery of 10,000 Tucki P7+ sets within four weeks after listing.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
Huize released its Q3 results in 2024, and the number of insured customers exceeded 10 million. On December 10th, HUIZ.US, an insurance e-commerce service platform, released its unaudited Q3 results report in the third quarter of 2024 (hereinafter referred to as "Q3") before the opening of the US stock market. The data shows that during Q3, Huixuan contributed a total premium of 2.06 billion yuan (RMB, the same below), a total revenue of 370 million yuan and a net profit of 18.7 million yuan. After experiencing rapid growth since the reform and opening up, China's economy is entering a new normal of medium-speed development. In 2024, opportunities and challenges coexist in the insurance industry. Q3 financial report data shows that Huixuan's accumulated insured customers have exceeded 10 million.Kanglongda: The company's products have not been directly sold to humanoid robots and aerospace manufacturing-related enterprises. Kanglongda said on the interactive platform on December 11 that the ultra-high molecular weight polyethylene (UHMWPE) fibers produced by the company are mainly used for industrial synergy, and the products sold abroad are mainly used in the fields of national defense and police, rope nets and belts. Up to now, the company's products have not been directly sold to humanoid robots and aerospace manufacturing related enterprises.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
On the 11th, soybean oil rose by 1.72%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract soybean oil closed at 2,505, up or down by +1.72%, with a turnover of 529,500 lots. The position data showed that the top 20 seats were clear, and the difference position was 59,880 lots. The total contract turnover of soybean oil futures was 685,800 lots, a decrease of 114,300 lots from the previous day. The first 20 seats in the contract held 687,800 lots, an increase of 15,900 lots over the previous day. The short positions in the top 20 seats of the contract were 775,600 lots, an increase of 3,312 lots over the previous day. (Sina Futures)The Israeli army warned Lebanese residents not to move to southern Lebanon. On the 11th local time, Adrahi, Arabic spokesperson of the Israel Defense Forces, posted a message on the social media platform, asking Lebanese residents not to move to more than 60 villages and their surrounding areas in southern Lebanon until further notice. The Israeli army provided a schematic diagram of the warning area and warned that anyone moving south of the area would put himself in danger. (CCTV News)Xpeng Motors: Tucki P7+ completed the formal delivery of 10,000 Tucki P7+ sets within four weeks after listing.
Strategy guide 12-14
Strategy guide
12-14